Mission statement · Company scope
“Our mission is to develop and commercialize innovative antibody-based therapeutics for the treatment of solid tumors that are designed to bind depending on the physical and chemical properties of tumors and their microenvironment.”
In use2026 – now1 sighting
First seenApr 2026Added
Last seenApr 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Product offering
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Plain
- Length
- 33 words · reading grade 21.3
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_f75f82866936d299
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-04-29 · sec_sentence · 10-K/A · accession 0001193125-26-191493
View filing ↗0 to compareCompare